{"id":1951,"date":"2005-01-01T12:05:00","date_gmt":"2005-01-01T11:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/behandlung-der-acne-vulgaris"},"modified":"2005-01-01T12:05:00","modified_gmt":"2005-01-01T11:05:00","slug":"behandlung-der-acne-vulgaris","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/behandlung-der-acne-vulgaris","title":{"rendered":"Behandlung der Acne vulgaris"},"content":{"rendered":"<p>Zur Therapie der Acne vulgaris (AV) erschien k\u00fcrzlich im JAMA ein sehr informativer kurzer \u00dcbersichtsartikel, dessen wichtigste Aussagen hier zusammengefa\u00dft werden sollen. Bei speziellem Interesse sollte man den Artikel von A. Haider und J.C. Shaw aus Toronto (1) mit ca. 100 Literaturzitaten klinischer Studien selbst lesen. In dem Review werden zun\u00e4chst die therapeutischen Substanzgruppen abgehandelt [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zur Therapie der Acne vulgaris (AV) erschien k\u00fcrzlich im JAMA ein sehr informativer kurzer \u00dcbersichtsartikel, dessen wichtigste Aussagen hier zusammengefa\u00dft werden sollen. Bei speziellem Interesse sollte man den Artikel von A. Haider und J.C. Shaw aus Toronto (1) mit ca. 100 Literaturzitaten klinischer Studien selbst lesen. In dem Review werden zun\u00e4chst die therapeutischen Substanzgruppen abgehandelt [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1361,4171,1371,396,399,4165,273,272,885,1025,642,1973,383,368],"class_list":["post-1951","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-acne-vulgaris","tag-adapalen","tag-akne","tag-all-trans-retinoinsaeure","tag-atra","tag-benzoylperoxid","tag-cyproteronacetat","tag-cyproteronazetat","tag-drospirenon","tag-ethinylestradiol","tag-isotretinoin","tag-minocyclin","tag-tazaroten","tag-tretinoin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1951"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1951\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}